UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Mayo Clinic proceedings, 2005-05, Vol.80 (5), p.587-595

2005

Volltextzugriff (PDF)

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study

Clinical therapeutics, 2002-11, Vol.24 (11), p.1871-1886

2002

Volltextzugriff (PDF)

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Mayo Clinic proceedings, 2006-09, Vol.81 (9), p.1177-1185

2006

Volltextzugriff (PDF)

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Menopause (New York, N.Y.), 2004-07, Vol.11 (4), p.405-415

2004

Volltextzugriff (PDF)

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

The American heart journal, 2005-03, Vol.149 (3), p.464-473

2005

Volltextzugriff (PDF)

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Clinical therapeutics, 2000-12, Vol.22 (12), p.1433-1442

2000

Volltextzugriff (PDF)

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

The American journal of geriatric pharmacotherapy, 2005-12, Vol.3 (4), p.218-228

2005

Volltextzugriff (PDF)

Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations

Drug Development for Rare Diseases, 2023, p.17-33

1, 2023

Volltextzugriff (PDF)

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Genomics (San Diego, Calif.), 2005-12, Vol.86 (6), p.648-656

2005

Volltextzugriff (PDF)

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Mayo Clinic proceedings, 2002-10, Vol.77 (10), p.1044-1052

2002

Volltextzugriff (PDF)

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)

The American heart journal, 2003-11, Vol.146 (5), p.862-869

2003

Volltextzugriff (PDF)

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

European heart journal, 2004-10, Vol.25 (19), p.1688-1694

2004

Volltextzugriff (PDF)

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

Clinical therapeutics, 2003-11, Vol.25 (11), p.2738-2753

2003

Volltextzugriff (PDF)

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A480-A481

2004

Volltextzugriff (PDF)

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

Diabetes care, 1998-12, Vol.21 (12), p.2129-2134

1998

Volltextzugriff (PDF)

861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A302-A302

2004

Volltextzugriff (PDF)

Cross-sectional analysis of renal function in black Americans with NIDDM

Diabetes care, 1990-11, Vol.13 (11), p.1186-1190

1990

Volltextzugriff (PDF)

Interaction of hypertension and diabetes on renal function in black NIDDM subjects

Kidney international, 1995-06, Vol.47 (6), p.1697-1702

1995

Volltextzugriff (PDF)

hugs & kisses

Off our backs, 1975-03, Vol.5 (3), p.24-24

palmisano, joanne

1975

Volltextzugriff (PDF)

tampons, acacia & honey

Off our backs, 1975-02, Vol.5 (2), p.24-24

1975

Volltextzugriff (PDF)

LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD

Medscape general medicine, 2005-07, Vol.7 (3), p.3

2005

Volltextzugriff (PDF)

Renal function in black Americans with Type II diabetes

The Journal of diabetic complications, 1989, Vol.3 (1), p.40-44

1989

Volltextzugriff (PDF)

Ventilatory Response to Carbon Dioxide in Term Infants After Halothane and Nitrous Oxide Anesthesia

Anesthesia and analgesia, 1993-06, Vol.76 (6), p.1234-1237

1993

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

Zeitschrift / SerieClinical Chemistry And Laboratory Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(19)

Publikationsform

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Female
(14)
Biological And Medical Sciences
(13)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Medical Sciences
(12)
Male
(11)
Middle Aged
(11)
Double-Blind Method
(9)
Aged
(7)
Adult
(6)
Drug Therapy, Combination
(6)
Ezetimibe
(6)
United States
(6)
Cholesterol, Ldl - Blood
(5)
Hypercholesterolemia - Drug Therapy
(5)
Cholesterol
(4)
Diabetes Mellitus, Type 2 - Physiopathology
(4)
Glomerular Filtration Rate
(4)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial

Cross-sectional analysis of renal function in black Americans with NIDDM

Interaction of hypertension and diabetes on renal function in black NIDDM subjects

hugs & kisses

tampons, acacia & honey

LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD

Renal function in black Americans with Type II diabetes

Ventilatory Response to Carbon Dioxide in Term Infants After Halothane and Nitrous Oxide Anesthesia

Aktive Filter

Suchergebnisse filtern